Shares Outstanding for Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported diluted shares outstanding is 898.00M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
LLY
Currently viewingShares OutstandingSwitch metric
Latest period
898.00M
YoY change
-0.7%
5Y CAGR
-1.3%
Peak year (1993)
1.20B
Latest annual
898.00M
Shares Outstanding history chart for Eli Lilly (LLY) from 1985 to 2025
Shares Outstanding history table for Eli Lilly (LLY) from 1985 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 898.00M | -0.7% | ||
| 2024 | 904.06M | +0.1% | ||
| 2023 | 903.28M | -4.9% | ||
| 2022 | 950.18M | -0.4% | ||
| 2021 | 953.65M | -0.3% | ||
| 2020 | 956.59M | -0.1% | ||
| 2019 | 957.53M | -7.4% | ||
| 2018 | 1.03B | -1.7% | ||
| 2017 | 1.05B | -4.4% | ||
| 2016 | 1.10B | -0.4% | ||
| 2015 | 1.11B | -0.5% | ||
| 2014 | 1.11B | -0.6% | ||
| 2013 | 1.12B | -2.6% | ||
| 2012 | 1.15B | +2.9% | ||
| 2011 | 1.11B | +0.7% | ||
| 2010 | 1.11B | +0.7% | ||
| 2009 | 1.10B | +0.4% | ||
| 2008 | 1.09B | +0.3% | ||
| 2007 | 1.09B | +0.4% | ||
| 2006 | 1.09B | -0.6% | ||
| 2005 | 1.09B | +0.3% | ||
| 2004 | 1.09B | +0.9% | ||
| 2003 | 1.08B | -0.2% | ||
| 2002 | 1.08B | -0.6% | ||
| 2001 | 1.09B | -0.5% | ||
| 2000 | 1.10B | -0.9% | ||
| 1999 | 1.11B | -1.3% | ||
| 1998 | 1.12B | -0.9% | ||
| 1997 | 1.13B | +1.2% | ||
| 1996 | 1.12B | -5.1% | ||
| 1995 | 1.18B | +0.8% | ||
| 1994 | 1.17B | -2.7% | ||
| 1993 | 1.20B | +3.3% | ||
| 1992 | 1.16B | -0.1% | ||
| 1991 | 1.16B | +1.1% | ||
| 1990 | 1.15B | -2.0% | ||
| 1989 | 1.17B | +3.4% | ||
| 1988 | 1.14B | -1.2% | ||
| 1987 | 1.15B | +5.0% | ||
| 1986 | 1.09B | -0.6% | ||
| 1985 | 1.10B | — |
Shares Outstanding values are taken from Eli Lilly's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted shares outstanding for Eli Lilly (LLY) came in at 898.00M – edged down 0.7% year-over-year.
Over 2020–2025 (5 years), Eli Lilly diluted shares outstanding expanded at a -1.3% compound annual rate, with a net decline across the window.
Eli Lilly diluted shares outstanding peaked at 1.20B in 1993; the latest annual figure is 898.00M in 2025 (25.2% below peak).
The dataset's maximum diluted shares outstanding sits at 1.20B (1993); the minimum reading of 898.00M dates to 2025.
Among 8 Healthcare peers, Eli Lilly (LLY) ranks 6th; the peer median for diluted shares outstanding is 1.34B.
Eli Lilly Shares Outstanding by Year
Eli Lilly Shares Outstanding 2025: 898.00M
Eli Lilly diluted shares outstanding in 2025 was 898.00M, edged down 0.7% below 2024. This figure represents the lowest annual value in the available history.
Eli Lilly Shares Outstanding 2024: 904.06M
Eli Lilly diluted shares outstanding in 2024 was 904.06M, edged up 0.1% from 2023.
Eli Lilly Shares Outstanding 2023: 903.28M
Eli Lilly diluted shares outstanding in 2023 was 903.28M, edged down 4.9% below 2022.
Eli Lilly Shares Outstanding 2022: 950.18M
Eli Lilly diluted shares outstanding in 2022 was 950.18M, edged down 0.4% below 2021.
Eli Lilly Shares Outstanding 2021: 953.65M
Eli Lilly diluted shares outstanding in 2021 was 953.65M.
See more financial history for Eli Lilly (LLY).
Sector peers — Shares Outstanding
Companies in the same sector as Eli Lilly, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | 377.00M | Healthcare |
Frequently asked questions
What is Eli Lilly's diluted shares outstanding?
- Latest reported diluted shares outstanding for Eli Lilly (LLY) is 898.00M (period ending December 31, 2025).
How has Eli Lilly diluted shares outstanding changed year-over-year?
- Eli Lilly (LLY) diluted shares outstanding changed -0.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Eli Lilly diluted shares outstanding?
- Eli Lilly (LLY) diluted shares outstanding compound annual growth rate is -1.3% over the most recent 5 years available.
When did Eli Lilly diluted shares outstanding hit its highest annual value?
- Eli Lilly diluted shares outstanding reached its highest annual value of 1.20B in 1993.
What was Eli Lilly diluted shares outstanding in 2024?
- Eli Lilly (LLY) diluted shares outstanding in 2024 was 904.06M.
What was Eli Lilly diluted shares outstanding in 2025?
- Eli Lilly (LLY) diluted shares outstanding in 2025 was 898.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LLY Overview
Company profile, financial tools, and key metrics
LLY Revenue Counter
Earns $2,067 every second. See per minute, hour, and day.
LLY Earnings Counter
Earns $654.44 per second net profit. See per minute, hour, and day.
LLY Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
LLY What If Invested
What if you had invested $1,000? See historical returns from any date.
LLY How It Makes Money
Discover visual breakdown of $65.18B in revenue — where it comes from and where it goes.
LLY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LLY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LLY Daily Price Character
Steady · 48.0% historical win rate (green days). Streaks & record days.
LLY Buybacks
0.43% TTM buyback yield. Shareholder yield & SBC comparison.
LLY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LLY Dividend Profile
Yield: 0.73%. Safety: 8/8. See full history.
LLY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LLY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.